Status:
COMPLETED
Review of Multimodality Management of Anaplastic Thyroid Cancer
Lead Sponsor:
Alberta Health services
Conditions:
Anaplastic Thyroid Cancer
Eligibility:
All Genders
Brief Summary
To describe the outcome of patients with anaplastic thyroid cancer treated with hyperfractionated radiotherapy and concomitant chemotherapy
Eligibility Criteria
Inclusion
- anaplastic thyroid cancer treated with multimodality treatment
Exclusion
- differentiated thyroid cancer
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2006
Estimated Enrollment :
5 Patients enrolled
Trial Details
Trial ID
NCT00280852
Start Date
January 1 2006
End Date
June 1 2006
Last Update
November 21 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tom Baker Cancer Centre
Calgary, Alberta, Canada, T2N 4N2